The joint effort between Fred Hutchinson Cancer Research Center and the Uganda Cancer Institute will benefit the world by identifying new infectious causes of cancer; new ways to prevent infection-associated cancers, such as the development of new vaccines; and new ways to treat such cancers with nontoxic drugs.
High-resolution photographs are available below for news media purposes only — no commercial usage is allowed. Please credit each photograph.
High-resolution photographs are available below for news media purposes only — no commercial usage is allowed. Please credit each photograph.
Dr. Larry Corey, co-director of the Vaccine and Infectious Disease Institute at Fred Hutchinson Cancer Research Center, and Dr. Jackson Orem, head of the Uganda Cancer Institute (UCI), tour the UCI facilities. For years, Orem was the only practicing oncologist in Uganda—a nation with more than 30 million people and one of the highest rates of cancer in the world. The genesis of the collaboration in Uganda was the Hutchinson Center’s focus on human herpesvirus, which began under Corey in the mid-'90s.
(Photo by Erica Sessle, Uganda Program on Cancer and Infectious Diseases)
(Photo by Erica Sessle, Uganda Program on Cancer and Infectious Diseases)
Dr. Larry Corey, co-director of the Vaccine and Infectious Disease Institute at Fred Hutchinson Cancer Research Center, and Dr. Jackson Orem, head of the Uganda Cancer Institute (UCI), tour the UCI facilities. For years, Orem was the only practicing oncologist in Uganda—a nation with more than 30 million people and one of the highest rates of cancer in the world. The genesis of the collaboration in Uganda was the Hutchinson Center’s focus on human herpesvirus, which began under Corey in the mid-'90s.
(Photo by Erica Sessle, Uganda Program on Cancer and Infectious Diseases)
(Photo by Erica Sessle, Uganda Program on Cancer and Infectious Diseases)
